JP Morgan Chase
AHCO icon

JP Morgan Chase’s AdaptHealth AHCO Stock Holding History

JP Morgan Chase’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-318,800
Closed -$11.7M – 6312
2021
Q1 		$11.7M Buy
+318,800
New +$11.3M ﹤0.01% 2216

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase's AHCO Position: Q1 2026 in Review

JP Morgan Chase reduced its AdaptHealth (AHCO) stake by 4.2% in Q1 2026, selling an estimated $77.6K and leaving 174,725 shares worth $1.97M. The position accounts for ﹤0.01% of the portfolio, ranked #4112.

JP Morgan Chase first reported a position in AHCO in Q2 2020 and has held it in 24 quarters since. The position peaked at $35.1M in Q1 2021. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • JP Morgan Chase held 174,725 shares of AdaptHealth worth $1.97M as of Q1 2026.
  • JP Morgan Chase sold 7,579 AdaptHealth shares in Q1 2026, an estimated $77.6K.
  • AdaptHealth made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4112 holding.
  • JP Morgan Chase first reported a position in AdaptHealth in Q2 2020 and has held it in 24 quarters since.
  • JP Morgan Chase's AdaptHealth position peaked at $35.1M in Q1 2021.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.